New treatment option for Heart Failure With Reduced Ejection Fraction
Official title A Study Investigating the Impact of IMT With CR On Exercise Responses In HF
ClinicalTrials.gov ID: NCT07086131
What this study is testing
- What it's testing
- The purpose of this study is to compare the impact of inspiratory muscle training (IMT) combined with cardiac rehabilitation (CR) on cardiovascular function in patients with heart failure.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- HFrEF Patients: (≥18 yrs) receiving guideline directed pharmacologic medical therapy for \>6 weeks (those with contraindications to medical therapy...
You likely can't join if
- sustained ventricular tachycardia and/or ventricular fibrillation within 21 days of visit 1;
- second or third degree heart block;
- body mass index \>45 kg/m2;
- current smokers and/or smoking history \>30 pack years;
- pregnant women (testing will be done by research team if requested);
- glomerular filtration rate of \<30 mL/min/1.73m2 (initial screen via clinical record within the past 6 months and this will be assessed on Visit 1);
See the full eligibility criteria
- HFrEF Patients: (≥18 yrs) receiving guideline directed pharmacologic medical therapy for \>6 weeks (those with contraindications to medical therapy will meet ), NYHA symptoms I-III, no hospitalizations in the \>3...
- sustained ventricular tachycardia and/or ventricular fibrillation within 21 days of visit 1;
- second or third degree heart block;
- body mass index \>45 kg/m2;
- current smokers and/or smoking history \>30 pack years;
- pregnant women (testing will be done by research team if requested);
- glomerular filtration rate of \<30 mL/min/1.73m2 (initial screen via clinical record within the past 6 months and this will be assessed on Visit 1);
- individuals who are not able to engage in exercise;
- symptomatic peripheral artery disease;
- asthmatic patients with a low symptom perception and suffer frequency, severe exacerbations or with an abnormally low perception of dyspnea;
- ruptured eardrum or any other condition of the ear;
- history of spontaneous pneumothorax or osteoporosis with a history of rib fractures;
- history of lung disease. For individuals agreeing to undergo dual energy x-ray absorptiometry (DEXA) scanning for measurement of body composition as part of their study visit, additional exclusion criteria apply...
The study team makes the final eligibility decision.
Where it's taking place
- Rochester, Minnesota, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Rochester, Minnesota, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.